Variant report

Variant	esv989438
Chromosome Location	chr12:42981066-42988699
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:492)
CpG islands
(count:794)
Chromatin interactive
region (count:8)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:492 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:42981639-42981670	HepG2	liver:	n/a	n/a
2	BACH1	chr12:42983611-42983906	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr12:42984246-42984643	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr12:42982800-42983141	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCLAF1	chr12:42983564-42983826	GM12878	blood:	n/a	chr12:42983763-42983776
6	CCNT2	chr12:42983171-42983827	K562	blood:	n/a	n/a
7	CEBPB	chr12:42981403-42981899	ECC-1	luminal epithelium:	n/a	n/a
8	CEBPB	chr12:42981485-42981834	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr12:42981405-42981878	ECC-1	luminal epithelium:	n/a	n/a
10	CEBPB	chr12:42981469-42981762	K562	blood:	n/a	n/a
11	CEBPB	chr12:42981448-42981833	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr12:42981361-42981919	MCF-7	breast:	n/a	n/a
13	CEBPB	chr12:42981464-42981832	HepG2	liver:	n/a	n/a
14	CEBPB	chr12:42987545-42987743	HepG2	liver:	n/a	chr12:42987587-42987600 chr12:42987588-42987599
15	CEBPB	chr12:42981473-42981840	K562	blood:	n/a	n/a
16	CEBPB	chr12:42981550-42981703	HepG2	liver:	n/a	n/a
17	CEBPB	chr12:42981413-42981847	IMR90	lung:	n/a	n/a
18	CEBPB	chr12:42981451-42981874	A549	lung:	n/a	n/a
19	CEBPB	chr12:42981460-42981833	A549	lung:	n/a	n/a
20	CEBPB	chr12:42981332-42981944	A549	lung:	n/a	n/a
21	CEBPB	chr12:42981389-42981899	MCF-7	breast:	n/a	n/a
22	CHD1	chr12:42983449-42983494	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD2	chr12:42983639-42983711	H1-hESC	embryonic stem cell:	n/a	n/a
24	CREB1	chr12:42983333-42983795	A549	lung:	n/a	n/a
25	CTBP2	chr12:42982768-42984725	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTCF	chr12:42984420-42984570	HFF	foreskin:	n/a	n/a
27	CTCF	chr12:42982800-42982950	HRPEpiC	eye:	n/a	chr12:42982868-42982889
28	CTCF	chr12:42982698-42982954	SK-N-SH_RA	brain:	n/a	chr12:42982868-42982889
29	CTCF	chr12:42983426-42983532	GM19239	blood:	n/a	n/a
30	CTCF	chr12:42982820-42982970	GM12870	blood:	n/a	chr12:42982868-42982889
31	CTCF	chr12:42982750-42983004	GM19239	blood:	n/a	chr12:42982868-42982889
32	CTCF	chr12:42982480-42982630	SK-N-SH_RA	brain:	n/a	n/a
33	CTCF	chr12:42982745-42983024	NHEK	skin:	n/a	chr12:42982868-42982889
34	CTCF	chr12:42982780-42982930	NB4	blood:	n/a	chr12:42982868-42982889
35	CTCF	chr12:42982790-42982964	A549	lung:	n/a	chr12:42982868-42982889
36	CTCF	chr12:42982820-42982970	AG04450	lung:	n/a	chr12:42982868-42982889
37	CTCF	chr12:42982800-42982950	HBMEC	blood vessel:	n/a	chr12:42982868-42982889
38	CTCF	chr12:42984540-42984690	AoAF	blood vessel:	n/a	chr12:42984591-42984609
39	CTCF	chr12:42984520-42984670	HRPEpiC	eye:	n/a	chr12:42984591-42984609
40	CTCF	chr12:42984440-42984590	NHEK	skin:	n/a	n/a
41	CTCF	chr12:42981400-42981550	HRPEpiC	eye:	n/a	chr12:42981435-42981443 chr12:42981462-42981475
42	CTCF	chr12:42984480-42984630	HUVEC	blood vessel:	n/a	chr12:42984591-42984609
43	CTCF	chr12:42982780-42982930	GM12867	blood:	n/a	chr12:42982868-42982889
44	CTCF	chr12:42982760-42982910	GM12870	blood:	n/a	chr12:42982868-42982889
45	CTCF	chr12:42984620-42984770	BE2_C	brain:	n/a	n/a
46	CTCF	chr12:42982763-42983060	K562	blood:	n/a	chr12:42982868-42982889
47	CTCF	chr12:42982780-42982930	A549	lung:	n/a	chr12:42982868-42982889
48	CTCF	chr12:42984520-42984670	MCF-7	breast:	n/a	chr12:42984591-42984609
49	CTCF	chr12:42982800-42982950	GM12872	blood:	n/a	chr12:42982868-42982889
50	CTCF	chr12:42984531-42984649	HUVEC	blood vessel:	n/a	chr12:42984591-42984609

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:42983805-42983855	BE2_C	brain:	n/a
2	chr12:42983805-42983855	BE2_C	brain:	n/a
3	chr12:42983805-42983855	AG09319	gingival:	n/a
4	chr12:42984114-42984164	GM12892	blood:	n/a
5	chr12:42984466-42984516	NHBE	bronchial:	n/a
6	chr12:42981814-42981864	GM12878	blood:	n/a
7	chr12:42984224-42984274	PrEC	prostate:	n/a
8	chr12:42984236-42984286	H1-hESC	embryonic stem cell:	embryo
9	chr12:42982929-42982979	CMK	blood:	n/a
10	chr12:42981814-42981864	SK-N-SH_RA	brain:	n/a
11	chr12:42983360-42983410	AoSMC	blood vessel:	n/a
12	chr12:42984337-42984387	GM19239	blood:	n/a
13	chr12:42984466-42984516	AG09309	skin:	n/a
14	chr12:42987806-42987856	HEK293	kidney:	embryo
15	chr12:42984224-42984274	HCPEpiC	choroid plexus:	n/a
16	chr12:42987806-42987856	ProgFib	skin:	n/a
17	chr12:42982649-42982699	HCF	heart:	n/a
18	chr12:42982419-42982469	HMEC	breast:	n/a
19	chr12:42984236-42984286	BE2_C	brain:	n/a
20	chr12:42984114-42984164	NT2-D1	testis:	n/a
21	chr12:42983805-42983855	SK-N-MC	brain:	n/a
22	chr12:42984093-42984143	HIPEpiC	eye:	n/a
23	chr12:42983360-42983410	GM12892	blood:	n/a
24	chr12:42984466-42984516	RPTEC	kidney:	n/a
25	chr12:42982419-42982469	SAEC	small airway:	n/a
26	chr12:42984114-42984164	GM19239	blood:	n/a
27	chr12:42984224-42984274	NT2-D1	testis:	n/a
28	chr12:42982929-42982979	PrEC	prostate:	n/a
29	chr12:42981814-42981864	Jurkat	blood:	n/a
30	chr12:42982929-42982979	PFSK-1	brain:	n/a
31	chr12:42984337-42984387	NH-A	brain:	n/a
32	chr12:42981814-42981864	HCM	heart:	n/a
33	chr12:42982929-42982979	T-47D	breast:	n/a
34	chr12:42984236-42984286	HCM	heart:	n/a
35	chr12:42982929-42982979	U87	brain:	n/a
36	chr12:42984114-42984164	HRCEpiC	kidney:	n/a
37	chr12:42983360-42983410	BJ	skin:	n/a
38	chr12:42984337-42984387	PFSK-1	brain:	n/a
39	chr12:42984337-42984387	NT2-D1	testis:	n/a
40	chr12:42981814-42981864	HUVEC	blood vessel:	n/a
41	chr12:42983360-42983410	HNPCEpiC	eye:	n/a
42	chr12:42982649-42982699	NT2-D1	testis:	n/a
43	chr12:42982649-42982699	BE2_C	brain:	n/a
44	chr12:42984114-42984164	ProgFib	skin:	n/a
45	chr12:42984466-42984516	PrEC	prostate:	n/a
46	chr12:42984236-42984286	BJ	skin:	n/a
47	chr12:42984236-42984286	CMK	blood:	n/a
48	chr12:42984466-42984516	HUVEC	blood vessel:	n/a
49	chr12:42984337-42984387	HMEC	breast:	n/a
50	chr12:42984093-42984143	HRCEpiC	kidney:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:42975394..42979509-chr12:42980340..42982880,4	K562	blood:
2	chr12:42978457..42981553-chr12:42981984..42984862,3	MCF-7	breast:
3	chr12:42985364..42987861-chr12:42992158..42994252,2	K562	blood:
4	chr12:42982454..42982981-chr12:43675696..43676627,2	MCF-7	breast:
5	chr12:42985364..42987568-chr12:42992752..42994313,2	K562	blood:
6	chr12:42982822..42983322-chr12:43730434..43730991,2	MCF-7	breast:
7	chr12:42982698..42983359-chr12:43198437..43199068,2	MCF-7	breast:
8	chr12:42984197..42984716-chr12:43676086..43676642,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZCRB1-2	chr12:42983267-42983546	NONHSAT027781

No data

Variant related genes	Relation type
PRICKLE1	TF binding region
PRICKLE1	CpG island
ENSG00000139174	chromatin interactions

Extended variants
information (count: 238 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:238 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527475875	chr12:42981079-42981080	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs144255600	chr12:42981093-42981094	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs570703644	chr12:42981116-42981117	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs537787689	chr12:42981144-42981145	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs117253051	chr12:42981200-42981201	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs569298670	chr12:42981206-42981207	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs536696506	chr12:42981302-42981303	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs4768421	chr12:42981304-42981305	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs541725755	chr12:42981323-42981324	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs187212988	chr12:42981326-42981327	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs561189229	chr12:42981374-42981375	Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs148713688	chr12:42981413-42981414	Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs534398122	chr12:42981505-42981506	Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs558913431	chr12:42981535-42981536	Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs577449962	chr12:42981642-42981643	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs2178750	chr12:42981646-42981647	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs556095616	chr12:42981650-42981651	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs574106258	chr12:42981683-42981684	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs560306343	chr12:42981686-42981687	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs559812876	chr12:42981751-42981752	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs527413607	chr12:42981752-42981753	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs561382272	chr12:42981761-42981762	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs545965297	chr12:42981778-42981779	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs564144891	chr12:42981808-42981809	Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs531607305	chr12:42981824-42981825	Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs374680214	chr12:42981869-42981870	Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs373881972	chr12:42981896-42981897	Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs572099199	chr12:42981965-42981966	Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs569233840	chr12:42981968-42981969	Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs530106176	chr12:42981974-42981975	Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs190505761	chr12:42982030-42982031	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs4768422	chr12:42982048-42982049	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs141484335	chr12:42982060-42982061	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
34	rs564915369	chr12:42982144-42982145	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
35	rs559073643	chr12:42982191-42982192	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
36	rs573569033	chr12:42982216-42982217	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs532230099	chr12:42982267-42982268	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs570978409	chr12:42982327-42982328	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs538483894	chr12:42982366-42982367	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs4768423	chr12:42982369-42982370	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs181674858	chr12:42982442-42982443	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs541404315	chr12:42982486-42982487	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs547205257	chr12:42982491-42982492	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs185619733	chr12:42982502-42982503	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs571776424	chr12:42982508-42982509	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs545604382	chr12:42982526-42982527	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs564261134	chr12:42982650-42982651	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs531413868	chr12:42982653-42982654	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs118143582	chr12:42982661-42982662	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs190383510	chr12:42982763-42982764	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Hirschsprung''s Disease	21712996	CNVD
Lissencephaly	21572526	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	21251322	CNVD
small cell lung cancer	20016488	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	19602461	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:581 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:42960400-42981400	Weak transcription	Fetal Muscle Trunk	muscle
2	chr12:42971000-42981400	Weak transcription	Stomach Mucosa	stomach
3	chr12:42975000-42981200	Enhancers	Fetal Stomach	stomach
4	chr12:42976600-42981400	Enhancers	Fetal Lung	lung
5	chr12:42977400-42981200	Enhancers	Duodenum Smooth Muscle	Duodenum
6	chr12:42978400-42981200	Active TSS	Fetal Kidney	kidney
7	chr12:42978600-42981200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr12:42978800-42981200	Weak transcription	NHLF	lung
9	chr12:42978800-42981400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
10	chr12:42979200-42981600	Flanking Active TSS	HUVEC	blood vessel
11	chr12:42979800-42981200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr12:42979800-42981200	Weak transcription	Adipose Nuclei	Adipose
13	chr12:42979800-42981200	Weak transcription	Right Atrium	heart
14	chr12:42979800-42981400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
15	chr12:42979800-42981400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr12:42979800-42981400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr12:42979800-42981400	Weak transcription	Aorta	Aorta
18	chr12:42979800-42981400	Weak transcription	Left Ventricle	heart
19	chr12:42979800-42981400	Weak transcription	Lung	lung
20	chr12:42979800-42981400	Weak transcription	Ovary	ovary
21	chr12:42979800-42981400	Weak transcription	Right Ventricle	heart
22	chr12:42979800-42982400	Weak transcription	Psoas Muscle	Psoas
23	chr12:42980000-42981200	Weak transcription	Skeletal Muscle Male	skeletal muscle
24	chr12:42980000-42985000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr12:42980200-42981200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr12:42980200-42981200	Weak transcription	Colon Smooth Muscle	Colon
27	chr12:42980200-42981200	Active TSS	Fetal Heart	heart
28	chr12:42980200-42981200	Weak transcription	Rectal Smooth Muscle	rectum
29	chr12:42980200-42981200	Weak transcription	HSMM	muscle
30	chr12:42980200-42981400	Weak transcription	Skeletal Muscle Female	skeletal muscle
31	chr12:42980600-42981200	Enhancers	Stomach Smooth Muscle	stomach
32	chr12:42980600-42981400	Enhancers	Muscle Satellite Cultured Cells	--
33	chr12:42980600-42981800	Weak transcription	Spleen	Spleen
34	chr12:42980600-42984200	Active TSS	HSMMtube	muscle
35	chr12:42980800-42981200	Enhancers	iPS-18 Cell Line	embryonic stem cell
36	chr12:42980800-42981200	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr12:42980800-42981200	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
38	chr12:42980800-42982000	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr12:42980800-42982200	Flanking Active TSS	HMEC	breast
40	chr12:42980800-42982200	Flanking Active TSS	Osteobl	bone
41	chr12:42980800-42982600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
42	chr12:42980800-42984200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
43	chr12:42981000-42981200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr12:42981000-42981200	Bivalent Enhancer	Fetal Brain Male	brain
45	chr12:42981000-42981200	Bivalent Enhancer	Fetal Intestine Small	intestine
46	chr12:42981000-42981400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr12:42981000-42981400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr12:42981000-42981400	Enhancers	NHEK	skin
49	chr12:42981000-42981600	Flanking Active TSS	NH-A	brain
50	chr12:42981000-42981800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links